Nicorandil in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

BACKGROUND: Nicorandil, as an adjunctive therapy with primary percutaneous coronary intervention (PCI), had controversial benefits in cardioprotection in patients with acute myocardial infarction (AMI). METHODS AND RESULTS: We performed a systematic review of randomized controlled trials (RCTs) comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Muli, Huang, Zheng, Xie, Haojun, Zhou, Zhongjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805586/
https://www.ncbi.nlm.nih.gov/pubmed/24167609
http://dx.doi.org/10.1371/journal.pone.0078231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805586/
https://www.ncbi.nlm.nih.gov/pubmed/24167609
http://dx.doi.org/10.1371/journal.pone.0078231

Ejemplares similares